Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2,4 Difluorobenzylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Solve low yield & high cost in fexuprazan intermediate production. New route with >50% yield, 50% cost reduction. Scale to 100MT/yr.